Molecular analyses revealed that, in almost all instances, CCS is positive for t(12;22)(q13;q12), a genetic event not seen in traditional malignant melanoma, that now provides a measure for differential molecular diagnosis [129]. The gene discussed is CCS; the disease is melanoma.